Vistagen Therapeutics (VTGN) Operating Leases (2019 - 2026)
Vistagen Therapeutics' Operating Leases came in at $63,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), down 92.0% from $783,000 a year earlier and down 74.7% from the prior quarter.
Vistagen Therapeutics (VTGN) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Vistagen Therapeutics' Operating Leases was $249,000, down 73.7% from FY2025.
- Operating Leases has declined in each of the last six fiscal years, with a five-year compound annual growth rate of -40.5% (FY2021 to FY2026).
- Going back by fiscal year, Operating Leases was $948,000 in FY2025 (-39.6%), $1.57 million in FY2024 (-25.9%), $2.12 million in FY2023 (-18.6%) and $2.61 million in FY2022 (-22.2%).
- The fiscal Q1 2027 figure represents the lowest quarterly Operating Leases in data going back to fiscal Q1 2020.
- Year-over-year, Operating Leases has declined for 25 consecutive quarters, with an average decline of 53.8% over the last eight quarters.
- Across the past five years, year-over-year decline in Operating Leases ran from 11.3% in fiscal Q2 2022 to 92.0% in fiscal Q1 2027.
- Business Quant data shows VTGN's Operating Leases at $249,000 (Q4 2026), $431,000 (Q3 2026) and $610,000 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - |
| 10 | Vistagen Therapeutics | 7.34 Mn | -151.60 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 63,000.00 |
| Mar 31, 2026 | 249,000.00 |
| Dec 31, 2025 | 431,000.00 |
| Sep 30, 2025 | 610,000.00 |
| Jun 30, 2025 | 783,000.00 |
| Mar 31, 2025 | 948,000.00 |
| Dec 31, 2024 | 1.11 Mn |
| Sep 30, 2024 | 1.27 Mn |
| Jun 30, 2024 | 1.42 Mn |
| Mar 31, 2024 | 1.57 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.85 Mn |
| Jun 30, 2023 | 1.99 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 2.25 Mn |
| Sep 30, 2022 | 2.37 Mn |
| Jun 30, 2022 | 2.49 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 2.72 Mn |
| Sep 30, 2021 | 3.14 Mn |
Vistagen Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=VTGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();